OK
The material selection platform
Cosmetics Ingredients
The material selection platform
Cosmetics Ingredients
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

Liposomal ampelopsin 1%

Technical Datasheet | Supplied by Lipomize
Dihydromyricetin (0.90-1.10%) (and) Carnitine Tartrate (and) Phospholipids (0.50-1.00%) (and) Tocopheryl Acetate (and) Propylene Glycol (and) Alcohol (and) Aqua. Liposomal ampelopsin 1% by Lipomize acts as a slimming agent. It contains liposomes made of soy phospholipids and ampelopsin.
  • The liposomal delivery system leads the active ingredients into the deepest layers of the skin.
  • It significantly reduces adipogenesis and lipogenesis and increases lipolysis.
  • Used in slimming formulations like creams, emulsions and gels used to treat thighs, hips, buttocks and abdomen.
  • Shelf life of Liposomal ampelopsin 1% is 18 months from date of packaging.
REQUEST A SAMPLE ORIGINAL DATASHEET CONTACT SUPPLIER
Liposomal ampelopsin 1%
Technical Datasheet | Supplied by Lipomize
REQUEST A SAMPLE ORIGINAL DATASHEET CONTACT SUPPLIER
Claims
Slimming Agents
Use Level
5-10%
Appearance
Translucent to opaque liquid
Odor
Characteristic
Color
Light greenish yellow to dark yellow
Product Status
COMMERCIAL
Applications/ Recommended for
  • Skin care > Body care > Slimming preparations
  • Creams, lotions & gels
Origin/Nature
Encapsulated Products & Delivery Systems: Microencapsulated, Phospholipids
Regulatory Status
US, EU

Liposomal ampelopsin 1% Properties

Property

Value & Unit
Test Condition
Test Method
pH
4 - 6
(Direct pH meter)
Particle Size
300 - 900 nm
(Dynamic Light Scattering)
Total Aerobic Microbial Count
< 1000 cfu/ml
Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 51890 Cosmetics Ingredients,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top